Titers and types of antineutrophil cytoplasmic antibodies (ANCAs) and titers of antinuclear antibodies (ANAs) and smooth muscle antibodies (ASMAs) contained in intravenous immunoglobulin preparations as demonstrated by IIF
| . | ANCA IgG . | ANCA IgA . | ANCA IgM . | ANA IgG . | ASMA IgG . |
|---|---|---|---|---|---|
| A1 | 1:1024* | 1:512* | 1:16* | 1:120† | 1:240‡ |
| A2 | 1:1024* | 1:512* | 1:64* | 1:60† | 1:240‡ |
| A3 | 1:512* | 1:512* | 1:32* | 1:60† | 1:240‡ |
| A4 | 1:512* | 1:256* | 1:32* | 1:30† | 1:120‡ |
| A5 | 1:2048* | NT | NT | NT | NT |
| B1 | 1:32* | – | – | 1:120† | – |
| B2 | 1:128* | 1:8* | – | 1:60† | – |
| C1 | 1:64* | – | – | 1:30† | – |
| C2 | 1:64* | NT | NT | NT | NT |
| D1 | 1:64§ | 1:128* | 1:256§ | 1:120† | – |
| D2 | 1:64* | NT | NT | NT | NT |
| D3 | 1:256* | NT | NT | NT | NT |
| E1 | 1:256* | 1:16* | – | 1:240† | – |
| . | ANCA IgG . | ANCA IgA . | ANCA IgM . | ANA IgG . | ASMA IgG . |
|---|---|---|---|---|---|
| A1 | 1:1024* | 1:512* | 1:16* | 1:120† | 1:240‡ |
| A2 | 1:1024* | 1:512* | 1:64* | 1:60† | 1:240‡ |
| A3 | 1:512* | 1:512* | 1:32* | 1:60† | 1:240‡ |
| A4 | 1:512* | 1:256* | 1:32* | 1:30† | 1:120‡ |
| A5 | 1:2048* | NT | NT | NT | NT |
| B1 | 1:32* | – | – | 1:120† | – |
| B2 | 1:128* | 1:8* | – | 1:60† | – |
| C1 | 1:64* | – | – | 1:30† | – |
| C2 | 1:64* | NT | NT | NT | NT |
| D1 | 1:64§ | 1:128* | 1:256§ | 1:120† | – |
| D2 | 1:64* | NT | NT | NT | NT |
| D3 | 1:256* | NT | NT | NT | NT |
| E1 | 1:256* | 1:16* | – | 1:240† | – |